Stephen Doberstein
Angel · Texas
Board director at 2 startups that filed Form D raises since late 2024, mostly in Texas.
- Stages
- Pre-seed, Series B
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Apr 2025
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Forte BiosciencesAug 9, 2023
- SEC Form D: Invea TherapeuticsApr 9, 2025
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.